Richard S. Geary - Aug 30, 2024 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP, Chief Development Officer
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Richard S. Geary
Stock symbol
IONS
Transactions as of
Aug 30, 2024
Transactions value $
$425
Form type
4
Date filed
9/4/2024, 09:41 PM
Previous filing
Sep 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Other $425 +11 +0.01% $38.64 84.8K Aug 30, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 30, 2024. These shares may not be sold until February 28, 2025.